These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 191204)

  • 21. [Viomycin and viomycin pantothenate with reduced toxicity in therapy of pulmonary tuberculosis].
    KUNTZ E
    Arzneimittelforschung; 1957 Apr; 7(4):233-7. PubMed ID: 13436325
    [No Abstract]   [Full Text] [Related]  

  • 22. The total structure of viomycin by sequential analysis.
    Kitagawa T; Miura T; Fujiwara K; Taniyama H
    Chem Pharm Bull (Tokyo); 1972 Oct; 20(10):2215-25. PubMed ID: 4346588
    [No Abstract]   [Full Text] [Related]  

  • 23. Catalytic hydrogenation of viomycin and capreomycin.
    Dyer JR; Carter JH; van Wyk PJ
    J Med Chem; 1971 Nov; 14(11):1120-1. PubMed ID: 4329900
    [No Abstract]   [Full Text] [Related]  

  • 24. Vinomycin I. The amino acid sequence of viomycin.
    Kitagawa T; Sawada Y; Miura T; Ozasa T; Taniyama H
    Tetrahedron Lett; 1968 Jan; 1():109-13. PubMed ID: 4298709
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical tests of viomycin-pantothenatesulfate (vionactan-P)].
    ARNOLD M
    Schweiz Z Tuberc Pneumonol; 1958; 15(4):203-10. PubMed ID: 13602779
    [No Abstract]   [Full Text] [Related]  

  • 26. Amino acids and peptides. V. Synthesis of amino acid derivatives containing a sulfonamide bond.
    Maeda M; Okada Y; Sogabe M; Kawasaki K
    Chem Pharm Bull (Tokyo); 1985 May; 33(5):2137-41. PubMed ID: 4053237
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experimental studies in vitro with viomycin panthothenate].
    COLOMBI GC; BASILICO F; TROTTA E
    G Ital Della Tuberc; 1958; 12(4):197-201. PubMed ID: 13574580
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of codon shortening and the antibiotics viomycin and sparsomycin upon the behaviour of bound aminoacyl-tRNA. Decoding at the ribosomal A site.
    Hornig H; Woolley P; Lührmann R
    FEBS Lett; 1983 Jun; 156(2):311-5. PubMed ID: 6303858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experimental and clinical importance of pantothenates of streptomycin, dihydrostreptomycin and viomycin].
    PREZIOSI P
    Riforma Med; 1958 Aug; 72(33):931-3. PubMed ID: 13579974
    [No Abstract]   [Full Text] [Related]  

  • 30. [Streptomycin, dihydrostreptomycin, neomycin & viomycin pantothenates].
    KELLER H
    G Ital Chemioter; 1957; 4(1-2):33-57. PubMed ID: 13562573
    [No Abstract]   [Full Text] [Related]  

  • 31. [Viomycin pantothenate in therapy-resistant primary tuberculosis in small children].
    RENOVANZ HD
    Kinderarztl Prax; 1958 Jul; 26(7):289-95. PubMed ID: 13576684
    [No Abstract]   [Full Text] [Related]  

  • 32. Mode of action of viomycin on Rhizobium meliloti.
    Jordan DC; Yamamura Y; McKague ME
    Can J Microbiol; 1969 Sep; 15(9):1005-12. PubMed ID: 4313425
    [No Abstract]   [Full Text] [Related]  

  • 33. The structure, stereochemistry and reactions of the guanidine moiety of viomycin.
    Bycoft BW; Croft LR; Johnson AW; Webb T
    J Antibiot (Tokyo); 1969 Mar; 22(3):133-4. PubMed ID: 4307101
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of primary tuberculous infection with viomycin pantothenate].
    SIMON K
    Pediatrie; 1958; 13(4):455-8. PubMed ID: 13600934
    [No Abstract]   [Full Text] [Related]  

  • 35. Enzyme immunoassay of viomycin. New cross-linking reagent for enzyme labelling and a preparation method for antiserum to viomycin.
    Kitagawa T; Fujitake T; Taniyama H; Aikawa T
    J Biochem; 1978 May; 83(5):1493-501. PubMed ID: 207686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Two years of experience with viomycin pantothenate-sulfate (vionactan) in the treatment of pulmonary tuberculosis].
    SCALFI GF; PONTIGGIA P; ROSSA G
    Minerva Med; 1958 Sep; 49(71):3343-56. PubMed ID: 13600139
    [No Abstract]   [Full Text] [Related]  

  • 37. Development of resistance by Mycobacterium tuberculosis to streptomycin, viomycin, and paraaminosalicylic acid.
    JOSIUKAS A; ROY TE; BOYD G
    AMA Am J Dis Child; 1952 Dec; 84(6):747-8. PubMed ID: 12996007
    [No Abstract]   [Full Text] [Related]  

  • 38. Viomycin. II. The structure of the chromophore.
    Bycroft BW; Cameron D; Croft LR; Hassanali-Walji A; Johnson AW; Webb T
    J Chem Soc Perkin 1; 1972; 6():827-34. PubMed ID: 4338113
    [No Abstract]   [Full Text] [Related]  

  • 39. [Bile acid derivatives with antimicrobial activity].
    Bellini AM; Vertuani G; Quaglio MP; Cavazzini G
    Farmaco Sci; 1979 Nov; 34(11):967-78. PubMed ID: 553828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viomycin. Further degradative studies.
    Bycroft BW; Cameron D; Croft LR; Johnson AW; Webb T; Coggon P
    Tetrahedron Lett; 1968 May; (25):2925-30. PubMed ID: 4297159
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.